Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.
Identifieur interne : 002801 ( PubMed/Corpus ); précédent : 002800; suivant : 002802Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.
Auteurs : Joong-Seok Kim ; Kwang-Soo Lee ; Sung-Chul Lim ; Jae-Young Ahn ; In-Uk Song ; Yeong-In Kim ; Bum-Soo Kim ; Hee-Tae KimSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2007.
English descriptors
- KwdEn :
- Adrenergic alpha-Agonists (therapeutic use), Brain (drug effects), Brain (pathology), Dementia, Vascular (complications), Dementia, Vascular (drug therapy), Dementia, Vascular (pathology), Humans, Magnetic Resonance Imaging (methods), Male, Middle Aged, Midodrine (therapeutic use), Multiple System Atrophy (complications), Multiple System Atrophy (drug therapy).
- MESH :
- chemical , therapeutic use : Adrenergic alpha-Agonists, Midodrine.
- complications : Dementia, Vascular, Multiple System Atrophy.
- drug effects : Brain.
- drug therapy : Dementia, Vascular, Multiple System Atrophy.
- methods : Magnetic Resonance Imaging.
- pathology : Brain, Dementia, Vascular.
- Humans, Male, Middle Aged.
Abstract
We describe a 51-year-old man with a 3-year history of multiple system atrophy, who developed a reversible posterior leukoencephalopathy syndrome (RPLS) after receiving prescription midodrine for therapeutic treatment of orthostatic hypotension. Typical reversible magnetic resonance imaging findings, following treatment with midodrine, suggested a possible relationship between midodrine treatment, supine hypertension, and RPLS, although a cause-and-effect relationship cannot be confirmed.
DOI: 10.1002/mds.21461
PubMed: 17377920
Links to Exploration step
pubmed:17377920Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.</title>
<author><name sortKey="Kim, Joong Seok" sort="Kim, Joong Seok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation><nlm:affiliation>Department of Neurology, The Catholic University of Korea, Seoul, Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lee, Kwang Soo" sort="Lee, Kwang Soo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author><name sortKey="Lim, Sung Chul" sort="Lim, Sung Chul" uniqKey="Lim S" first="Sung-Chul" last="Lim">Sung-Chul Lim</name>
</author>
<author><name sortKey="Ahn, Jae Young" sort="Ahn, Jae Young" uniqKey="Ahn J" first="Jae-Young" last="Ahn">Jae-Young Ahn</name>
</author>
<author><name sortKey="Song, In Uk" sort="Song, In Uk" uniqKey="Song I" first="In-Uk" last="Song">In-Uk Song</name>
</author>
<author><name sortKey="Kim, Yeong In" sort="Kim, Yeong In" uniqKey="Kim Y" first="Yeong-In" last="Kim">Yeong-In Kim</name>
</author>
<author><name sortKey="Kim, Bum Soo" sort="Kim, Bum Soo" uniqKey="Kim B" first="Bum-Soo" last="Kim">Bum-Soo Kim</name>
</author>
<author><name sortKey="Kim, Hee Tae" sort="Kim, Hee Tae" uniqKey="Kim H" first="Hee-Tae" last="Kim">Hee-Tae Kim</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21461</idno>
<idno type="RBID">pubmed:17377920</idno>
<idno type="pmid">17377920</idno>
<idno type="wicri:Area/PubMed/Corpus">002801</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.</title>
<author><name sortKey="Kim, Joong Seok" sort="Kim, Joong Seok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation><nlm:affiliation>Department of Neurology, The Catholic University of Korea, Seoul, Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lee, Kwang Soo" sort="Lee, Kwang Soo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author><name sortKey="Lim, Sung Chul" sort="Lim, Sung Chul" uniqKey="Lim S" first="Sung-Chul" last="Lim">Sung-Chul Lim</name>
</author>
<author><name sortKey="Ahn, Jae Young" sort="Ahn, Jae Young" uniqKey="Ahn J" first="Jae-Young" last="Ahn">Jae-Young Ahn</name>
</author>
<author><name sortKey="Song, In Uk" sort="Song, In Uk" uniqKey="Song I" first="In-Uk" last="Song">In-Uk Song</name>
</author>
<author><name sortKey="Kim, Yeong In" sort="Kim, Yeong In" uniqKey="Kim Y" first="Yeong-In" last="Kim">Yeong-In Kim</name>
</author>
<author><name sortKey="Kim, Bum Soo" sort="Kim, Bum Soo" uniqKey="Kim B" first="Bum-Soo" last="Kim">Bum-Soo Kim</name>
</author>
<author><name sortKey="Kim, Hee Tae" sort="Kim, Hee Tae" uniqKey="Kim H" first="Hee-Tae" last="Kim">Hee-Tae Kim</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic alpha-Agonists (therapeutic use)</term>
<term>Brain (drug effects)</term>
<term>Brain (pathology)</term>
<term>Dementia, Vascular (complications)</term>
<term>Dementia, Vascular (drug therapy)</term>
<term>Dementia, Vascular (pathology)</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging (methods)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Midodrine (therapeutic use)</term>
<term>Multiple System Atrophy (complications)</term>
<term>Multiple System Atrophy (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-Agonists</term>
<term>Midodrine</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Dementia, Vascular</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dementia, Vascular</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Dementia, Vascular</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We describe a 51-year-old man with a 3-year history of multiple system atrophy, who developed a reversible posterior leukoencephalopathy syndrome (RPLS) after receiving prescription midodrine for therapeutic treatment of orthostatic hypotension. Typical reversible magnetic resonance imaging findings, following treatment with midodrine, suggested a possible relationship between midodrine treatment, supine hypertension, and RPLS, although a cause-and-effect relationship cannot be confirmed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17377920</PMID>
<DateCreated><Year>2007</Year>
<Month>05</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted><Year>2007</Year>
<Month>08</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>22</Volume>
<Issue>7</Issue>
<PubDate><Year>2007</Year>
<Month>May</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.</ArticleTitle>
<Pagination><MedlinePgn>1043-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We describe a 51-year-old man with a 3-year history of multiple system atrophy, who developed a reversible posterior leukoencephalopathy syndrome (RPLS) after receiving prescription midodrine for therapeutic treatment of orthostatic hypotension. Typical reversible magnetic resonance imaging findings, following treatment with midodrine, suggested a possible relationship between midodrine treatment, supine hypertension, and RPLS, although a cause-and-effect relationship cannot be confirmed.</AbstractText>
<CopyrightInformation>(c) 2007 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Joong-Seok</ForeName>
<Initials>JS</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, The Catholic University of Korea, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Kwang-Soo</ForeName>
<Initials>KS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lim</LastName>
<ForeName>Sung-Chul</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ahn</LastName>
<ForeName>Jae-Young</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Song</LastName>
<ForeName>In-Uk</ForeName>
<Initials>IU</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Yeong-In</ForeName>
<Initials>YI</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Bum-Soo</ForeName>
<Initials>BS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Hee-Tae</ForeName>
<Initials>HT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000316">Adrenergic alpha-Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6YE7PBM15H</RegistryNumber>
<NameOfSubstance UI="D008879">Midodrine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000316">Adrenergic alpha-Agonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015140">Dementia, Vascular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008879">Midodrine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019578">Multiple System Atrophy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>8</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21461</ArticleId>
<ArticleId IdType="pubmed">17377920</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002801 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002801 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:17377920 |texte= Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17377920" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |